Jove
Visualize
Contact Us

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Survival Tree01:19

Survival Tree

118
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
118
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

298
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
298
Actuarial Approach01:20

Actuarial Approach

101
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
101

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expanded antigen-specific donor regulatory T cells for GVHD prevention.

Blood·2026
Same author

Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma.

Journal for immunotherapy of cancer·2026
Same author

Dual inhibition of glycolysis and epigenetics via a nanodelivery system for colorectal cancer treatment.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.

Nature communications·2026
Same author

Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors.

Translational lung cancer research·2026
Same author

Mitigating Spurious Invariance in Contrastive Learning: A Probabilistic Self-Supervised Learning Framework for Medical Image Analysis.

IEEE transactions on medical imaging·2026
Same journal

Correction to 'SyMetrics: an integrated machine learning model for evaluating the pathogenicity of synonymous variants in the human genome'.

NAR genomics and bioinformatics·2026
Same journal

asms: finding allele-specific methylation in human genomes without phasing.

NAR genomics and bioinformatics·2026
Same journal

An epigenetic clock for chronological age estimation in East Asian populations.

NAR genomics and bioinformatics·2026
Same journal

The role of ATF4 in neurons under mitochondrial stress.

NAR genomics and bioinformatics·2026
Same journal

Distinct repeat architecture landscapes in the proteomes of protozoan parasites.

NAR genomics and bioinformatics·2026
Same journal

Long non-coding RNA triplex-dependent regulation of melanoma gene networks.

NAR genomics and bioinformatics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 26, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Prediction-oriented prognostic biomarker discovery with survival machine learning methods.

Sijie Yao1, Biwei Cao1, Tingyi Li1

  • 1Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

NAR Genomics and Bioinformatics
|June 19, 2023
PubMed
Summary
This summary is machine-generated.

This study compares machine learning methods for selecting prognostic biomarkers to predict cancer survival. Boosting-based approaches showed superior accuracy and better performance in complex scenarios for personalized treatment strategies.

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Related Experiment Videos

Last Updated: Jul 26, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.9K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K

Area of Science:

  • Biomedical Informatics
  • Computational Biology
  • Machine Learning in Oncology

Background:

  • Accurate prognostic biomarkers are crucial for personalized cancer treatment strategies.
  • High-dimensional data in cancer research necessitates effective feature selection for predictive models.
  • The performance of feature selection methods in survival models requires further investigation.

Purpose of the Study:

  • To construct and compare prediction-oriented biomarker selection frameworks using advanced machine learning algorithms.
  • To evaluate the efficacy of different machine learning approaches for prognostic biomarker identification in survival models.
  • To adapt the Prediction-Oriented Marker Selection (PROMISE) method for survival analysis (PROMISE-Cox) as a benchmark.

Main Methods:

  • Leveraged machine learning algorithms: random survival forests, extreme gradient boosting, light gradient boosting, and deep learning-based survival models.
  • Adapted the PROMISE method for survival models (PROMISE-Cox) as a benchmark.
  • Conducted simulation studies to assess performance metrics like accuracy, true positive rate, and false positive rate.

Main Results:

  • Boosting-based approaches (extreme gradient boosting, light gradient boosting) demonstrated superior predictive accuracy.
  • These methods also exhibited better true positive and false positive rates in complex scenarios.
  • The study successfully identified prognostic biomarkers in head and neck cancer data using the proposed strategies.

Conclusions:

  • Boosting-based machine learning methods are highly effective for prognostic biomarker selection in survival analysis.
  • These advanced techniques improve prediction accuracy and mitigate overfitting in high-dimensional cancer data.
  • The findings support the use of these methods for developing personalized treatment strategies in oncology.